1,247.71
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt NFLX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$1,263.25
Offen:
$1263.975
24-Stunden-Volumen:
2.24M
Relative Volume:
0.73
Marktkapitalisierung:
$530.18B
Einnahmen:
$41.46B
Nettoeinkommen (Verlust:
$10.25B
KGV:
53.16
EPS:
23.47
Netto-Cashflow:
$8.50B
1W Leistung:
+1.81%
1M Leistung:
+3.03%
6M Leistung:
+44.04%
1J Leistung:
+85.32%
Netflix Inc Stock (NFLX) Company Profile
Firmenname
Netflix Inc
Sektor
Branche
Telefon
408-540-3700
Adresse
121 ALBRIGHT WAY, LOS GATOS
Vergleichen Sie NFLX mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
NFLX
Netflix Inc
|
1,247.71 | 528.93B | 41.46B | 10.25B | 8.50B | 23.47 |
![]()
DIS
Walt Disney Co
|
115.81 | 213.67B | 94.13B | 12.55B | 11.55B | 6.38 |
![]()
LYV
Live Nation Entertainment Inc
|
170.83 | 39.29B | 23.72B | 775.11M | 1.08B | 2.31 |
![]()
WBD
Warner Bros Discovery Inc
|
12.54 | 30.58B | 38.41B | 640.00M | 4.07B | 0.30 |
![]()
FWONK
Liberty Media Corp
|
98.87 | 25.46B | 3.51B | -102.00M | 737.00M | -0.42 |
Netflix Inc Stock (NFLX) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-07-10 | Bestätigt | KeyBanc Capital Markets | Overweight |
2025-07-07 | Herabstufung | Seaport Research Partners | Buy → Neutral |
2025-07-02 | Bestätigt | Canaccord Genuity | Buy |
2025-07-02 | Bestätigt | Goldman | Neutral |
2025-06-20 | Bestätigt | Pivotal Research Group | Buy |
2025-06-12 | Bestätigt | Oppenheimer | Outperform |
2025-06-03 | Bestätigt | Jefferies | Buy |
2025-05-30 | Bestätigt | BofA Securities | Buy |
2025-05-19 | Herabstufung | JP Morgan | Overweight → Neutral |
2025-04-21 | Bestätigt | BMO Capital Markets | Outperform |
2025-04-21 | Bestätigt | Barclays | Equal Weight |
2025-04-21 | Bestätigt | Canaccord Genuity | Buy |
2025-04-21 | Bestätigt | Guggenheim | Buy |
2025-04-21 | Bestätigt | JP Morgan | Overweight |
2025-04-21 | Bestätigt | KeyBanc Capital Markets | Overweight |
2025-04-21 | Bestätigt | MoffettNathanson | Buy |
2025-04-21 | Bestätigt | Morgan Stanley | Overweight |
2025-04-21 | Bestätigt | Oppenheimer | Outperform |
2025-04-21 | Bestätigt | Piper Sandler | Overweight |
2025-04-21 | Bestätigt | Pivotal Research Group | Buy |
2025-04-21 | Bestätigt | Wells Fargo | Overweight |
2025-04-17 | Fortgesetzt | Piper Sandler | Overweight |
2025-03-27 | Eingeleitet | FBN Securities | Outperform |
2025-03-17 | Hochstufung | MoffettNathanson | Neutral → Buy |
2025-01-24 | Hochstufung | Bernstein | Mkt Perform → Outperform |
2025-01-23 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
2025-01-22 | Hochstufung | Barclays | Underweight → Equal Weight |
2025-01-22 | Hochstufung | Canaccord Genuity | Hold → Buy |
2025-01-22 | Bestätigt | Oppenheimer | Outperform |
2025-01-22 | Bestätigt | Pivotal Research Group | Buy |
2025-01-22 | Hochstufung | Rosenblatt | Neutral → Buy |
2025-01-22 | Hochstufung | The Benchmark Company | Sell → Hold |
2025-01-16 | Hochstufung | Seaport Research Partners | Neutral → Buy |
2025-01-15 | Bestätigt | BMO Capital Markets | Outperform |
2025-01-15 | Bestätigt | Oppenheimer | Outperform |
2025-01-08 | Bestätigt | Goldman | Neutral |
2025-01-06 | Bestätigt | Argus | Buy |
2025-01-03 | Bestätigt | The Benchmark Company | Sell |
2024-12-19 | Bestätigt | UBS | Buy |
2024-12-16 | Herabstufung | Loop Capital | Buy → Hold |
2024-12-16 | Bestätigt | Oppenheimer | Outperform |
2024-12-11 | Bestätigt | JP Morgan | Overweight |
2024-11-20 | Bestätigt | Pivotal Research Group | Buy |
2024-10-18 | Bestätigt | Needham | Buy |
2024-10-18 | Bestätigt | Oppenheimer | Outperform |
2024-10-18 | Bestätigt | Pivotal Research Group | Buy |
2024-10-16 | Bestätigt | Loop Capital | Buy |
2024-10-11 | Bestätigt | Guggenheim | Buy |
2024-10-10 | Bestätigt | Morgan Stanley | Overweight |
2024-10-10 | Bestätigt | Oppenheimer | Outperform |
2024-10-07 | Herabstufung | Barclays | Equal Weight → Underweight |
2024-10-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
2024-10-01 | Bestätigt | KeyBanc Capital Markets | Overweight |
2024-09-05 | Eingeleitet | China Renaissance | Hold |
2024-08-30 | Bestätigt | Pivotal Research Group | Buy |
2024-07-17 | Bestätigt | Guggenheim | Buy |
2024-07-16 | Bestätigt | The Benchmark Company | Sell |
2024-07-15 | Bestätigt | BofA Securities | Buy |
2024-07-12 | Bestätigt | JP Morgan | Overweight |
2024-07-10 | Bestätigt | KeyBanc Capital Markets | Overweight |
2024-07-09 | Bestätigt | TD Cowen | Buy |
2024-07-02 | Bestätigt | Argus | Buy |
2024-05-28 | Bestätigt | Evercore ISI | Outperform |
2024-04-19 | Herabstufung | Canaccord Genuity | Buy → Hold |
2024-04-19 | Hochstufung | Needham | Hold → Buy |
2024-04-19 | Bestätigt | Pivotal Research Group | Buy |
2024-04-15 | Bestätigt | Deutsche Bank | Hold |
2024-04-12 | Bestätigt | Morgan Stanley | Overweight |
2024-04-12 | Bestätigt | Piper Sandler | Neutral |
2024-04-05 | Bestätigt | Pivotal Research Group | Buy |
2024-03-25 | Bestätigt | Citigroup | Neutral |
2024-03-12 | Bestätigt | Jefferies | Buy |
2024-03-11 | Bestätigt | Oppenheimer | Outperform |
2024-01-30 | Herabstufung | Seaport Research Partners | Buy → Neutral |
2024-01-25 | Hochstufung | DZ Bank | Hold → Buy |
2024-01-24 | Bestätigt | BMO Capital Markets | Outperform |
2024-01-24 | Bestätigt | BofA Securities | Buy |
2024-01-24 | Bestätigt | Canaccord Genuity | Buy |
2024-01-24 | Bestätigt | Evercore ISI | Outperform |
2024-01-24 | Bestätigt | Goldman | Neutral |
2024-01-24 | Bestätigt | Guggenheim | Buy |
2024-01-24 | Bestätigt | JP Morgan | Overweight |
2024-01-24 | Bestätigt | KeyBanc Capital Markets | Overweight |
2024-01-24 | Hochstufung | Macquarie | Neutral → Outperform |
2024-01-24 | Bestätigt | Morgan Stanley | Overweight |
2024-01-24 | Bestätigt | Oppenheimer | Outperform |
2024-01-24 | Bestätigt | Piper Sandler | Neutral |
2024-01-24 | Bestätigt | Pivotal Research Group | Buy |
2024-01-24 | Bestätigt | Redburn Atlantic | Buy |
2024-01-24 | Bestätigt | Robert W. Baird | Outperform |
2024-01-24 | Bestätigt | TD Cowen | Outperform |
2024-01-24 | Bestätigt | UBS | Buy |
2024-01-24 | Bestätigt | Wells Fargo | Overweight |
2023-09-18 | Bestätigt | Evercore ISI | Outperform |
2023-08-25 | Hochstufung | Loop Capital | Hold → Buy |
2023-07-24 | Hochstufung | Robert W. Baird | Neutral → Outperform |
2023-07-17 | Bestätigt | Deutsche Bank | Buy |
2023-07-13 | Bestätigt | JP Morgan | Overweight |
2023-07-12 | Bestätigt | UBS | Buy |
2023-07-05 | Hochstufung | Goldman | Sell → Neutral |
2023-06-29 | Bestätigt | Citigroup | Buy |
2023-06-28 | Bestätigt | Oppenheimer | Outperform |
2023-06-13 | Bestätigt | BofA Securities | Buy |
2023-06-13 | Bestätigt | Guggenheim | Buy |
2023-04-19 | Bestätigt | Deutsche Bank | Buy |
2023-04-19 | Bestätigt | JP Morgan | Overweight |
2023-04-19 | Bestätigt | Jefferies | Buy |
2023-04-19 | Bestätigt | Piper Sandler | Neutral |
2023-04-19 | Bestätigt | Pivotal Research Group | Buy |
2023-04-19 | Bestätigt | Rosenblatt | Neutral |
2023-04-19 | Hochstufung | UBS | Neutral → Buy |
2023-04-11 | Fortgesetzt | Robert W. Baird | Neutral |
2023-01-23 | Bestätigt | Argus | Buy |
2023-01-20 | Bestätigt | Canaccord Genuity | Buy |
2023-01-20 | Bestätigt | Deutsche Bank | Buy |
2023-01-20 | Bestätigt | Evercore ISI | Outperform |
2023-01-20 | Bestätigt | Goldman | Sell |
2023-01-20 | Bestätigt | Guggenheim | Buy |
2023-01-20 | Bestätigt | Jefferies | Buy |
2023-01-20 | Bestätigt | MoffettNathanson | Market Perform |
2023-01-20 | Bestätigt | Oppenheimer | Outperform |
2023-01-20 | Bestätigt | Piper Sandler | Neutral |
2023-01-20 | Bestätigt | Pivotal Research Group | Buy |
2023-01-20 | Bestätigt | Robert W. Baird | Neutral |
2023-01-20 | Bestätigt | The Benchmark Company | Sell |
2023-01-20 | Bestätigt | Wedbush | Outperform |
2023-01-20 | Bestätigt | Wolfe Research | Outperform |
2023-01-12 | Hochstufung | Jefferies | Hold → Buy |
2023-01-04 | Eingeleitet | New Street | Neutral |
2022-12-29 | Hochstufung | CFRA | Sell → Buy |
2022-12-14 | Bestätigt | Jefferies | Hold |
2022-12-09 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
2022-06-14 | Herabstufung | The Benchmark Company | Hold → Sell |
2022-06-10 | Herabstufung | Goldman | Neutral → Sell |
2022-05-16 | Hochstufung | Wedbush | Neutral → Outperform |
2022-04-21 | Herabstufung | DZ Bank | Buy → Hold |
2022-04-21 | Herabstufung | Edward Jones | Buy → Hold |
2022-04-20 | Herabstufung | Atlantic Equities | Overweight → Neutral |
2022-04-20 | Herabstufung | BofA Securities | Buy → Underperform |
2022-04-20 | Herabstufung | JP Morgan | Overweight → Neutral |
2022-04-20 | Hochstufung | Needham | Underperform → Hold |
2022-04-20 | Herabstufung | Oppenheimer | Outperform → Perform |
2022-04-20 | Herabstufung | Piper Sandler | Overweight → Neutral |
2022-04-20 | Herabstufung | Pivotal Research Group | Buy → Sell |
2022-04-20 | Herabstufung | Stifel | Buy → Hold |
2022-04-20 | Herabstufung | UBS | Buy → Neutral |
2022-04-20 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
2022-04-19 | Eingeleitet | Rosenblatt | Neutral |
2022-03-09 | Hochstufung | Wedbush | Underperform → Neutral |
2022-01-31 | Hochstufung | Citigroup | Neutral → Buy |
2022-01-31 | Hochstufung | Edward Jones | Hold → Buy |
2022-01-24 | Herabstufung | Jefferies | Buy → Hold |
2022-01-21 | Bestätigt | BMO Capital Markets | Outperform |
2022-01-21 | Bestätigt | BofA Securities | Buy |
2022-01-21 | Bestätigt | Canaccord Genuity | Buy |
2022-01-21 | Bestätigt | Cowen | Outperform |
2022-01-21 | Bestätigt | Deutsche Bank | Hold |
2022-01-21 | Bestätigt | Goldman | Neutral |
2022-01-21 | Bestätigt | Guggenheim | Buy |
2022-01-21 | Bestätigt | JP Morgan | Overweight |
2022-01-21 | Bestätigt | MoffettNathanson | Neutral |
2022-01-21 | Herabstufung | Monness Crespi & Hardt | Buy → Neutral |
2022-01-21 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2022-01-21 | Bestätigt | Oppenheimer | Outperform |
2022-01-21 | Bestätigt | Piper Sandler | Overweight |
2022-01-21 | Bestätigt | Pivotal Research Group | Buy |
2022-01-21 | Herabstufung | Robert W. Baird | Outperform → Neutral |
2022-01-21 | Bestätigt | Stifel | Buy |
2022-01-21 | Hochstufung | The Benchmark Company | Sell → Hold |
2022-01-21 | Herabstufung | Truist | Buy → Hold |
2022-01-21 | Bestätigt | UBS | Buy |
2022-01-21 | Bestätigt | Wolfe Research | Outperform |
2021-12-15 | Bestätigt | The Benchmark Company | Sell |
2021-10-20 | Herabstufung | Deutsche Bank | Buy → Hold |
2021-10-20 | Bestätigt | Monness Crespi & Hardt | Buy |
2021-09-29 | Bestätigt | The Benchmark Company | Sell |
2021-09-13 | Eingeleitet | Goldman | Neutral |
2021-09-08 | Bestätigt | JP Morgan | Overweight |
2021-09-07 | Bestätigt | Atlantic Equities | Overweight |
2021-07-21 | Bestätigt | Credit Suisse | Outperform |
2021-07-21 | Bestätigt | Deutsche Bank | Buy |
2021-07-21 | Bestätigt | JP Morgan | Overweight |
2021-07-21 | Bestätigt | KeyBanc Capital Markets | Overweight |
2021-07-21 | Bestätigt | Stifel | Buy |
2021-06-25 | Hochstufung | Credit Suisse | Neutral → Outperform |
2021-06-25 | Eingeleitet | Edward Jones | Hold |
2021-05-19 | Fortgesetzt | Jefferies | Buy |
2021-04-21 | Fortgesetzt | Oppenheimer | Outperform |
2021-04-21 | Bestätigt | Pivotal Research Group | Buy |
2021-04-21 | Hochstufung | Stifel | Hold → Buy |
2021-04-06 | Fortgesetzt | Evercore ISI | Outperform |
2021-04-01 | Eingeleitet | Piper Sandler | Overweight |
2021-03-25 | Bestätigt | The Benchmark Company | Sell |
2021-03-23 | Hochstufung | Argus | Hold → Buy |
2021-01-21 | Hochstufung | DZ Bank | Hold → Buy |
2021-01-20 | Bestätigt | Monness Crespi & Hardt | Buy |
2021-01-20 | Bestätigt | Pivotal Research Group | Buy |
2021-01-20 | Bestätigt | The Benchmark Company | Sell |
2021-01-20 | Hochstufung | UBS | Neutral → Buy |
2021-01-20 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
2020-10-21 | Bestätigt | BMO Capital Markets | Outperform |
2020-10-21 | Bestätigt | Bernstein | Outperform |
2020-10-21 | Bestätigt | Jefferies | Buy |
2020-10-21 | Bestätigt | Morgan Stanley | Overweight |
2020-10-21 | Bestätigt | Oppenheimer | Outperform |
2020-10-21 | Bestätigt | Piper Sandler | Overweight |
2020-10-21 | Bestätigt | Pivotal Research Group | Buy |
2020-10-21 | Bestätigt | RBC Capital Mkts | Outperform |
2020-10-21 | Bestätigt | The Benchmark Company | Sell |
2020-10-21 | Bestätigt | Wedbush | Underperform |
2020-10-21 | Bestätigt | Wells Fargo | Equal Weight |
2020-10-16 | Bestätigt | Morgan Stanley | Overweight |
2020-10-15 | Bestätigt | Canaccord Genuity | Buy |
2020-10-14 | Bestätigt | Goldman | Buy |
2020-10-07 | Bestätigt | Pivotal Research Group | Buy |
2020-09-28 | Bestätigt | The Benchmark Company | Sell |
2020-09-15 | Eingeleitet | KeyBanc Capital Markets | Overweight |
2020-09-09 | Fortgesetzt | Raymond James | Mkt Perform |
2020-09-04 | Bestätigt | The Benchmark Company | Sell |
2020-07-29 | Bestätigt | Loop Capital | Buy |
Alle ansehen
Netflix Inc Aktie (NFLX) Neueste Nachrichten
Netflix Chief Product Officer Eunice Kim to Exit After 5 Years - IMDb
Netflix's chief product officer Eunice Kim to leave - Yahoo Finance
Eunice Kim resigns as product chief of Netflix; CTO to fill in temporarily (NFLX:NASDAQ) - Seeking Alpha
Eunice Kim Out as Netflix’s Chief Product Officer - Variety
Netflix Chief Product Officer Eunice Kim Is Leaving the Company - Bloomberg.com
Netflix, Inc. $NFLX Shares Sold by Jacobs Levy Equity Management Inc. - MarketBeat
Gotham Asset Management LLC Sells 2,428 Shares of Netflix, Inc. $NFLX - MarketBeat
Netflix is teaming up with Amazon, and it's dragging down adtech rival The Trade Desk's stock - Business Insider Africa
Meghan and Harry's $30m Montecito Netflix Mansion Struggles To Sell - Newsweek
NFLX vs. PSKY: Which Streaming Giant Has Better Upside Potential? - Yahoo Finance
Netflix's High Labor Productivity Is A 'Strong Positive' For Shareholders,' Says Bullish Analyst - Benzinga
Netflix and Amazon tie up for programmatic ads partnership (AMZN:NASDAQ) - Seeking Alpha
Amazon Ads, Netflix partner on programmatic buying - breakingthenews.net
Netflix And Amazon Set Advertising Alliance - ca.finance.yahoo.com
Victoria Beckham Netflix Docuseries Sets October Premiere Date - Variety
Love Explosion: Netflix Releases a Fun and Emotional Official Trailer for the Film 'Caramelo', Starring Rafael Vitti and the Dog Amendoim - About Netflix
Amazon and Netflix Ink Major Advertising Deal - uk.finance.yahoo.com
Netflix, Amazon Set Alliance to Broaden Connected-TV Impressions for Ad Buyers - Yahoo Movies UK
Ben Affleck, Matt Damon Find Hidden Money in Netflix’s ‘The Rip’ Trailer - IMDb
Advisory Alpha LLC Raises Stake in Netflix, Inc. $NFLX - MarketBeat
Ben Affleck & Matt Damon's Netflix Crime Thriller Debuts First Explosive Trailer - MovieWeb
Matt Damon and Ben Affleck’s Crime Thriller ‘The Rip’ Gets Pulse-Pounding First Trailer - TheWrap
Is Netflix Stock an Nvidia-Level Winner? - Mitrade
Netflix, Inc. $NFLX is Zurich Insurance Group Ltd FI's 10th Largest Position - MarketBeat
Netflix, Inc. $NFLX Shares Sold by Alpha DNA Investment Management LLC - MarketBeat
Netflix, Inc. $NFLX Holdings Raised by UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC - MarketBeat
Netflix, Inc. $NFLX Stake Decreased by Integrated Wealth Concepts LLC - MarketBeat
Charlie Brooker sets crime ‘drama’ at Netflix - Televisual
MBB Public Markets I LLC Takes $324,000 Position in Netflix, Inc. $NFLX - MarketBeat
‘Frankenstein’: Behind-the-Scenes Exhibition on Guillermo del Toro’s Netflix Film Coming to London Next Month - IMDb
Empowered Funds LLC Raises Holdings in Netflix, Inc. $NFLX - MarketBeat
Rip Road Capital Partners LP Has $5.06 Million Stake in Netflix, Inc. $NFLX - MarketBeat
Jones Financial Companies Lllp Reduces Position in Netflix, Inc. $NFLX - MarketBeat
Spain’s YouPlanet Launches Studios Division, Taps Beltrán Gortázar as CEO (Exclusive) - IMDb
‘Mahabharata’ Gets Netflix India Animated Treatment With Epic Series ‘Kurukshetra’ - IMDb
People Now Spend On Netflix, Inc. (NFLX) Instead Of Shopping, Says Jim Cramer - MSN
‘aka Charlie Sheen’ Review: Netflix Doc Offers a Reflective but Exhausting Look at the Actor’s Stardom and Notoriety - IMDb
Netflix’s ‘aka Charlie Sheen’ Is a Frustrating, Salacious Self-Portrait: TV Review - IMDb
Classical music is not Netflix, says Latvian mezzo-soprano Elina Garanca - Princeton Clarion
‘Wayward’ Review: Toni Collette Leads a Quirky Cult for Kids in Mae Martin’s Curious Netflix Thriller - IMDb
Netflix, Inc. $NFLX Shares Sold by Sandler Capital Management - MarketBeat
Netflix, Inc. $NFLX Shares Purchased by Nippon Life Global Investors Americas Inc. - MarketBeat
Here's What Broadcom Hitting an All-Time High Means for the "Magnificent Seven" and the "Ten Titans" Growth Stocks - The Motley Fool
Ben Affleck & Matt Damon Reunite in Thrilling New Look at Netflix Crime Thriller - MovieWeb
Petrus Trust Company LTA Purchases Shares of 557 Netflix, Inc. $NFLX - MarketBeat
Top 6 Movies About AI You Can Watch Right Now - IMDb
Gerard Butler's 82% RT Rated Action Thriller Is Already Leaving Netflix After Becoming a Streaming Hit - MovieWeb
Netflix (NFLX) Rises Higher Than Market: Key Facts - Yahoo Finance
NatWest Group plc Decreases Holdings in Netflix, Inc. $NFLX - MarketBeat
‘Wednesday’ Season 2 Part 2 Opens to 28 Million Views on Netflix, Down 43% From Part 1 - IMDb
Top 10 Movies and Shows on Netflix: Week of September 1, 2025 - IMDb
Finanzdaten der Netflix Inc-Aktie (NFLX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Netflix Inc-Aktie (NFLX) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Neumann Spencer Adam | Chief Financial Officer |
Sep 02 '25 |
Sale |
1,207.76 |
2,600 |
3,140,167 |
3,691 |
HASTINGS REED | Director |
Sep 02 '25 |
Option Exercise |
109.96 |
25,959 |
2,854,452 |
26,353 |
HASTINGS REED | Director |
Sep 02 '25 |
Sale |
1,207.71 |
25,959 |
31,351,002 |
394 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):